首页> 美国卫生研究院文献>PLoS Clinical Trials >A Single Cell Level Based Method for Copy Number Variation Analysis by Low Coverage Massively Parallel Sequencing
【2h】

A Single Cell Level Based Method for Copy Number Variation Analysis by Low Coverage Massively Parallel Sequencing

机译:低覆盖度大规模并行测序的单细胞水平拷贝数变异分析方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Copy number variations (CNVs), a common genomic mutation associated with various diseases, are important in research and clinical applications. Whole genome amplification (WGA) and massively parallel sequencing have been applied to single cell CNVs analysis, which provides new insight for the fields of biology and medicine. However, the WGA-induced bias significantly limits sensitivity and specificity for CNVs detection. Addressing these limitations, we developed a practical bioinformatic methodology for CNVs detection at the single cell level using low coverage massively parallel sequencing. This method consists of GC correction for WGA-induced bias removal, binary segmentation algorithm for locating CNVs breakpoints, and dynamic threshold determination for final signals filtering. Afterwards, we evaluated our method with seven test samples using low coverage sequencing (4∼9.5%). Four single-cell samples from peripheral blood, whose karyotypes were confirmed by whole genome sequencing analysis, were acquired. Three other test samples derived from blastocysts whose karyotypes were confirmed by SNP-array analysis were also recruited. The detection results for CNVs of larger than 1 Mb were highly consistent with confirmed results reaching 99.63% sensitivity and 97.71% specificity at base-pair level. Our study demonstrates the potential to overcome WGA-bias and to detect CNVs (>1 Mb) at the single cell level through low coverage massively parallel sequencing. It highlights the potential for CNVs research on single cells or limited DNA samples and may prove as a promising tool for research and clinical applications, such as pre-implantation genetic diagnosis/screening, fetal nucleated red blood cells research and cancer heterogeneity analysis.
机译:拷贝数变异(CNV)是与各种疾病相关的常见基因组突变,在研究和临床应用中很重要。全基因组扩增(WGA)和大规模并行测序已应用于单细胞CNV分析,这为生物学和医学领域提供了新见识。但是,WGA引起的偏差显着限制了CNV检测的灵敏度和特异性。为了解决这些局限性,我们开发了一种实用的生物信息学方法,可使用低覆盖率大规模并行测序技术在单个细胞水平检测CNV。该方法包括用于WGA引起的偏差消除的GC校正,用于定位CNV断点的二进制分段算法以及用于最终信号滤波的动态阈值确定。之后,我们使用低覆盖率测序(4%至9.5%)对七个测试样品进行了评估。从外周血中获取了四个单核细胞样本,其核型已通过全基因组测序分析得到确认。还招募了另外三个来自胚泡的测试样品,其核型已通过SNP阵列分析确认。大于1 Mb的CNV的检测结果与已证实的结果高度一致,在碱基对水平上的确证结果达到了99.63%的灵敏度和97.71%的特异性。我们的研究证明了通过低覆盖率大规模平行测序在单细胞水平上克服WGA偏倚和检测CNV(> 1 Mb)的潜力。它强调了在单个细胞或有限的DNA样品上进行CNV研究的潜力,并可能被证明是用于研究和临床应用的有前途的工具,例如植入前的基因诊断/筛选,胎儿有核红细胞研究和癌症异质性分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号